Sodium copper chlorophyllin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sodium copper chlorophyllin, covering 2026-02-04 to 2026-02-04. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity. [Phase 3]